Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 11-12, 2008, Pages 983-985

  Fica, Alberto E ^a   Abusada, Nancy J ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ATENOLOL; CREATININE; DEXAMETHASONE; ERTAPENEM; FAMOTIDINE; FUROSEMIDE; LACTULOSE; METRONIDAZOLE; OMEPRAZOLE; ONDANSETRON; PARACETAMOL; PAROXETINE; PHENYTOIN; POTASSIUM CHLORIDE; RISPERIDONE; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CONVULSION; CREATININE CLEARANCE; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MALE; MEDICAL AUDIT; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT DURATION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RISK FACTORS; SEIZURES;

EID: 57049134630     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540802375570     Document Type: Article

References (16)

1. Teppler, H., Gesser, RM, Friedland, IR, Woods, GL, Meibohm, A. Herman, G. et al. (2004) Safety and tolerability of ertapenem. J Antimicrob Chemother, 53, pp. 85-95.
2. Sharma, A. and Raina, V. (2001) Generalized seizure following ondansetron. Ann Oncol, 12, pp. 131-132.
3. von Einsiedel, RW, Roesch-Ely, D., Diebold, K., Sartor, K., Mundt, C. and Bergemann, N. (2002) H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. Pharmacopsychiatry, 35, pp. 152-154.
4. Beloosesky, Y., Grosman, B., Marmelstein, V. and Grinblat, J. (2000) Convulsions induced by metronidazole treatment for Clostridium difficile associated disease in chronic renal failure. Am J Med Sci, 319, pp. 338-339.
5. Naranjo, CA, Busto, U., Sellers, EM, Sandor, P., Ruiz, I. Roberts, EA et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 30, pp. 239-245.
6. Norrby, SR and Gildon, KM. (1999) Safety profile of meropenem: A review of nearly 5000 patients treated with meropenem. Scand J Infect Dis, 31, pp. 3-10.
7. Norrby, SR. (2000) Neurotoxicity of carbapenem antibiotics: Consequences for their use in bacterial meningitis. J Antimicrob Chemother, 45, pp. 5-7.
8. Seto, AH, Song, JC and Guest, SS. (2005) Ertapenem associated seizures in a peritoneal dialysis patient. Ann Pharmacother, 39, pp. 352-356.
9. Saidel-Odes, L., Borer, A., Riesenberg, K., Smolyakov, R. and Schlaeffer, F. (2006) History of cerebrovascular events: A relative contraindication to ertapenem therapy. Clin Infect Dis, 43, pp. 262-263.
10. Ong, C., Chua, AC, Tambyah, PA and Fei, YS. (2008) Seizures associated with ertapenem. Int J Antimicrob Agents, 31, p. 290.
11. Lunde, JL, Nelson, RE and Storandt, HF. (2007) Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy. Pharmacotherapy, 27, pp. 1202-1205.
12. Livermore, DM, Oakton, KJ, Carter, MW and Warner, M. (2001) Activity of ertapenem (MK-0826) versus enterobacteriaceae with potent β-lactamases. Antimicrob Agents Chemother, 45, pp. 2831-2837.
13. Brink, AJ, Feldman, C., Grolman, DC, Muckart, D., Pretorius, J. Richards, GA et al. (2004) Appropriate use of the carbapenems. S Afr Med J, 94, pp. 857-861.
14. De Sarro, A., Ammendola, D., Zappala, M., Grasso, S. and De Sarro, GB. (1995) Relationship between structure and convulsant properties of some β-lactam antibiotics following intrecerebroventricular microinjection in rats. Antimicrob Agents Chemother, 39, pp. 232-237.
15. Day, IP, Goudie, J., Nishiki, K. and Williams, PD. (1995) Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Toxicol Lett, 76, pp. 239-243.
16. Mistry, GC, Majumdar, AK, Swan, S., Sica, D., Fihser, A. Xu, Y. et al. (2006) Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on haemodialysis. J Clin Pharmacol, 46, pp. 1128-1138.